Order Article Reprints

Kubik P, Gallo D, Tanda ML, Jankau J, Rauso R, Gruszczyński W, Pawłowska A, Chrapczyński P, Malinowski M, Grzanka D, et al. Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records. Gels. 2023; 9(6):440. https://doi.org/10.3390/gels9060440

Kubik, Paweł, Daniela Gallo, Maria Laura Tanda, Jerzy Jankau, Raffaele Rauso, Wojciech Gruszczyński, Aleksandra Pawłowska, Paweł Chrapczyński, Maciej Malinowski, Dariusz Grzanka, and et al. 2023. "Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records" Gels 9, no. 6: 440. https://doi.org/10.3390/gels9060440

Kubik, P., Gallo, D., Tanda, M. L., Jankau, J., Rauso, R., Gruszczyński, W., Pawłowska, A., Chrapczyński, P., Malinowski, M., Grzanka, D., Smolińska, M., Antosik, P., Piesiaków, M.-L., Łukasik, B., Pawłowska-Kubik, A., Stabile, G., Guida, S., Kodłubański, Ł., Decates, T., & Zerbinati, N. (2023). Evaluation of the Safety of Neauvia Stimulate Injectable Product in Patients with Autoimmune Thyroid Diseases Based on Histopathological Examinations and Retrospective Analysis of Medical Records. Gels, 9(6), 440. https://doi.org/10.3390/gels9060440